Purpose
|
Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R, Kit, and Flt3 with IC50 of 20 nM, 10 nM and 160 nM, respectively. Phase 3.
|
Characteristics
|
Target: c-Kit inhibitor, FLT3 inhibitor Receptor: Kit,CSF-1R,FLT3
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C20H15ClF3N5
|
Solubility
|
DMSO > 100mM
|